(19)
(11) EP 2 935 299 A2

(12)

(88) Date of publication A3:
06.11.2014

(43) Date of publication:
28.10.2015 Bulletin 2015/44

(21) Application number: 13828822.0

(22) Date of filing: 13.12.2013
(51) International Patent Classification (IPC): 
C07H 3/06(2006.01)
C07K 1/107(2006.01)
A61K 47/48(2006.01)
A61K 39/09(2006.01)
(86) International application number:
PCT/IB2013/060933
(87) International publication number:
WO 2014/097099 (26.06.2014 Gazette 2014/26)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 20.12.2012 US 201261740311 P

(71) Applicant: Pfizer Inc.
New York, NY 10017 (US)

(72) Inventors:
  • HAN, Mingming
    Nazareth, Pennsylvania 18064 (US)
  • KAINTHAN, Rajesh Kumar
    Tappan, New York 10983 (US)
  • KIM, Jin-Hwan
    Suffern, New York 10901 (US)
  • PRASAD, Avvari Krishna
    Chapel Hill, North Carolina 27516 (US)

(74) Representative: Pfizer 
European Patent Department 23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14
75668 Paris Cedex 14 (FR)

   


(54) GLYCOCONJUGATION PROCESS